Published in Br J Exp Pathol on June 01, 1983
Active immunotherapy for acute lymphoblastic leukaemia. Lancet (1969) 13.03
Potentiation of T-cell-mediated immunity by selective suppression of antibody formation with cyclophosphamide. J Exp Med (1974) 5.73
B cell mitogenic properties of thymus-independent antigens. Nat New Biol (1973) 1.80
Inhibition of inflammatory response of skin to Staphylococcus aureus by high polymer levan. Br J Exp Pathol (1956) 1.17
Infection-promoting activity of levan and dextran as a function of degree of polymerization. Br J Exp Pathol (1954) 1.12
Binding of microorganisms to the macrophage plasma membrane; effects of enzymes and periodate. Br J Exp Pathol (1978) 0.94
Effects of high-molecular levan on the growth and spread of lymphoma in AKR mice. Cancer Res (1975) 0.89
Suppression of humoral immune response in mice by administration of high molecular levan. Experientia (1978) 0.88
Direct antitumor effect of high-molecular-weight levan on Lewis lung carcinoma cells in mice. J Natl Cancer Inst (1980) 0.86
Effect of dose and route of Bacillus Calmette-Guérin in chemoimmunostimulation therapy of a murine leukemia. Cancer Res (1973) 0.84
Effects of route and schedule of administration of high-molecular levan on the growth of AKR lymphoma. Cancer Res (1976) 0.83
Effect of polysaccharides on the formation of granulation tissue. AMA Arch Pathol (1956) 0.83
Effects of isoprinosine, levamisole, muramyl dipeptide, and SM1213 on lymphocyte and macrophage function in vitro. Cancer Treat Rep (1978) 0.83
Selective suppression of humoral and cellular immunity with cytosine arabinoside. Cancer Res (1972) 0.82
The role of macrophages and polymorphs in the levan-induced inhibition of Lewis lung carcinoma in C57BL mice. Br J Cancer (1979) 0.81
Preliminary observations on the effect of glucan in combination with radiation and chemotherapy in four murine tumors. Cancer Treat Rep (1978) 0.81
Effects of exposure of murine peritoneal exudate and resident macrophages to high molecular levan: a morphological study. J Pathol (1977) 0.81
Inhibition of 3LL carcinoma of mice by levan treatment. Isr J Med Sci (1977) 0.80
Mechanism of the inhibitory effect of levan on experimental tumors. Recent Results Cancer Res (1980) 0.79
Effects of dose and schedule of immune stimulant on efficacy of combination Corynebacterium parvum-cyclophosphamide treatment for a murine mammary adenocarcinoma. Cancer Res (1979) 0.78
Dextran derivatives in single and combination chemotherapy against transplantable mouse ascites and solid tumors. Cancer Res (1977) 0.78
Immunochemotherapy of transplanted KMT-17 tumor in WKA rats by combination of cyclophosphamide and immunostimulatory protein-bound polysaccharide isolated from basidiomycetes. Cancer Res (1977) 0.78
Management of alimentary tract duplication in children. Br J Surg (1995) 2.26
Are the polarization colors of picrosirius red-stained collagen determined only by the diameter of the fibers? Histochemistry (1989) 1.91
Evaluation of the dye-protein tracers in pathophysiology of the blood-brain barrier. Acta Neuropathol (1981) 1.58
Wolman disease: suggestions for effective treatment. Turk J Pediatr (1993) 1.39
Inbred strains of laboratory animals: superior to outbred mice? J Natl Cancer Inst (1995) 1.37
Insufficient stocking of poisoning antidotes in hospital pharmacies. JAMA (1996) 1.27
Polarized light microscopy in the study of the molecular structure of collagen and reticulin. Histochemistry (1986) 1.24
The role of smooth muscle cells and hematogenous macrophages in atheroma. J Pathol (1977) 1.17
Amyloid, its nature and molecular structure. Comparison of a new toluidine blue polarized light method with traditional procedures. Lab Invest (1971) 1.08
The cause of the green polarization color of amyloid stained with Congo red. Histochemie (1965) 1.07
Lipid pigments (chromolipids): their origin, nature, and significance. Pathobiol Annu (1980) 1.05
Polarized light microscopy as a tool of diagnostic pathology. J Histochem Cytochem (1975) 1.03
On the use of polarized light in pathology. Pathol Annu (1970) 1.01
The inhibitory effects of high molecular levan on transport across the vascular wall stimulated by histamine. J Pathol (1978) 0.99
Biological peroxidation of lipids and membranes. Isr J Med Sci (1975) 0.95
The tissue reaction to implanted foreign bodies in levan-treated mice. Pathology (1978) 0.92
Histochemical study of the nature of the asymmetry of cell membranes. Histochemie (1967) 0.91
Effects of high-molecular levan on the growth and spread of lymphoma in AKR mice. Cancer Res (1975) 0.89
Primary familial xanthomatosis with adrenal involvement (Wolman's disease). Report of a further case with nervous system involvement and pathogenetic considerations. Pediatrics (1968) 0.89
Structure of the myelin sheath as a function of concentration of ions. Biochim Biophys Acta (1965) 0.89
Connective tissue nevi collagens. Study with picrosirius red and polarizing microscopy. Am J Dermatopathol (1991) 0.88
Suppression of humoral immune response in mice by administration of high molecular levan. Experientia (1978) 0.88
Direct antitumor effect of high-molecular-weight levan on Lewis lung carcinoma cells in mice. J Natl Cancer Inst (1980) 0.86
Involvement of nervous tissue in primary familial xanthomatosis with adrenal calcification. Pathol Eur (1968) 0.85
Different patterns of macrophage activation induced by various agents. Cell Mol Biol Incl Cyto Enzymol (1981) 0.84
A polarized light study of collagen in dermal wound healing. Br J Exp Pathol (1972) 0.84
Histochemical study of the blue autofluorescence of collagen in oral irritation fibroma: effects of age of patients and of the duration of lesions. Histol Histopathol (1994) 0.83
Macrophage-recognized molecules of apoptotic cells are expressed at higher levels in AKR lymphoma of aged as compared to young mice. Adv Exp Med Biol (2000) 0.83
Effects of route and schedule of administration of high-molecular levan on the growth of AKR lymphoma. Cancer Res (1976) 0.83
Orientation of collagen in wound healing. Br J Exp Pathol (1974) 0.82
Animal models for tumor progression (short review). Anticancer Res (1984) 0.81
A model for cancer treatment in advanced compared to early cancer. Anticancer Res (1987) 0.81
Experimentally produced hypertension and aortic acid esterase. Arch Pathol Lab Med (1976) 0.81
Effect of levan on the stages of development of experimental allergic encephalomyelitis. Isr J Med Sci (1976) 0.81
Effect of native levan on homograft rejection in mice. Proc Soc Exp Biol Med (1975) 0.81
Oxidation of lipids and membranes II: Effects of oxidants on cerebral white matter homogenates. J Supramol Struct (1975) 0.81
The role of macrophages and polymorphs in the levan-induced inhibition of Lewis lung carcinoma in C57BL mice. Br J Cancer (1979) 0.81
Effects of exposure of murine peritoneal exudate and resident macrophages to high molecular levan: a morphological study. J Pathol (1977) 0.81
A fluorescent histochemical procedure for gamma-aminobutyric acid. Histochemie (1971) 0.81
Inhibition of 3LL carcinoma of mice by levan treatment. Isr J Med Sci (1977) 0.80
Different biological behavior of AKR lymphoma cells from primary and metastatic tumors. Experientia (1985) 0.80
Acid esterase as a factor in atheromatosis. Atherosclerosis (1974) 0.80
Metastatic potential and multidrug resistance correlation in the B16 melanoma system. J Exp Ther Oncol (1996) 0.80
Inhibitory effeft of oxidized spermine on the multiplication of coliphage T5. J Mol Biol (1966) 0.80
Histochemical study on the pathogenesis of chlorocyclizine-induced pulmonary lipidosis. Histochemistry (1979) 0.80
Spontaneous AKR lymphomas differ in their degree of malignancy and sensitivity to the polysaccharide levan. Experientia (1983) 0.79
Mechanism of the inhibitory effect of levan on experimental tumors. Recent Results Cancer Res (1980) 0.79
Oxidation of lipids and membranes I: in vitro formation of peroxidative lipid polymers. J Supramol Struct (1975) 0.79
Comparison of growth rate of two B16 melanomas differing in metastatic potential in young versus middle-aged mice. Cancer Invest (1997) 0.79
Etiology and pathogenesis of the hemolytic-uremic syndrome. A hypothesis. Isr J Med Sci (1972) 0.79
Ultrastructural aspects of the adherence to target cells of in vitro differentiated lymphocytes. Proc Soc Exp Biol Med (1975) 0.79
Histological criteria for immunological rejection of mouse skin homografts. J Pathol (1977) 0.79
[Macrophages and smooth muscle cells in the pathogenesis of atherosclerosis]. Harefuah (1976) 0.79
Acid esterase in the aorta of the hyperlipidemic rat: a histochemical study. Pathol Eur (1975) 0.79
Serial passage of tumors in mice in the study of tumor progression and testing of antineoplastic drugs. Cancer Res (1984) 0.79
Augmentative effects of intracellular chemotherapy penetration combined with hyperthermia in human ovarian cancer cells lines. Gynecol Oncol (1994) 0.78
Role of immune response as determinant of tumor progression in function of host age in the B16 melanoma. Mech Ageing Dev (1995) 0.78
Phagocytic system stimulation in experimental atherosclerosis of chicks. Exp Mol Pathol (1988) 0.78
Antiphage action of oxidized polyamines. Isr J Med Sci (1965) 0.78
Pathophysiologic correlations in the blood-brain barrier damage due to air embolism. Adv Neurol (1978) 0.78
Histochemistry of demyelination and myelination. J Histochem Cytochem (1968) 0.78
Modification of the tuberculin reaction by levan. Br J Exp Pathol (1978) 0.77
Kawasaki's disease and infantile polyarteritis nodosa: is Pseudomonas infection responsible? Report of a case. Isr J Med Sci (1979) 0.77
Does a cytoplasmic bridge connect the CNS axon with the inner loop of myelin? Cell Mol Biol (Noisy-le-grand) (1993) 0.77
[Properties of threonine deaminase from wild type and a valine sensitive mutant of Bacillus subtilis]. Bull Soc Chim Biol (Paris) (1969) 0.77
T cell receptor Ddelta2Ddelta3 rearrangement: a suitable allele-specific marker for the detection of minimal residual disease in childhood acute lymphoblastic leukemia. Leukemia (1997) 0.77
Effect of hyperthermia and thermochemotherapy on primary and metastatic tumour cells of AKR lymphoma. Int J Exp Pathol (1990) 0.77
Increase in cell permeability to a cytotoxic agent by the polysaccharide levan. Cell Mol Biol (1985) 0.77
Comparison of splenectomy effects as an indication for host response to growth of primary and metastatic tumour cells in two murine tumour systems. Int J Exp Pathol (1995) 0.77
Distribution of various protein fractions in central and peripheral myelin. Exp Neurol (1971) 0.77
Storage of polyvinylpyrrolidone mimicking a congenital mucolipid storage disease in a patient with Munchausen's syndrome. Isr J Med Sci (1975) 0.77
Immunoglobulin kappa gene rearrangements between the kappa deleting element and Jkappa recombination signal sequences in acute lymphoblastic leukemia and normal hematopoiesis. Leukemia (2000) 0.77
Histological changes in spleen and lymph nodes of mice administered cyclophosphamide and levan. Cell Tissue Res (1986) 0.77
Direct antitumor effect of the polysaccharide levan in mice: effects of drug concentration and time and temperature of incubation. J Natl Cancer Inst (1984) 0.77
Malignant phenotype correlating with drug resistance in two human neuroblastoma cell lines. J Neurooncol (1994) 0.77
Effect of splenectomy on treatment of Lewis lung carcinoma by an immunomodulatory polysaccharide and a cytotoxic agent. J Surg Oncol (1987) 0.77
Effects of chlorocyclizine on pulmonary lipid metabolism in rats. Biochim Biophys Acta (1983) 0.77
Macrophage activation in the prevention or regression of atherosclerosis. Adv Exp Med Biol (1984) 0.76
Effect of splenectomy on the efficiency of chemo-immunotherapy of melanoma-bearing mice. Int J Immunopharmacol (1985) 0.76
Effect of lectins on tumorigenicity of AKR lymphoma cells of varying malignancy. Anticancer Res (1987) 0.76
The role of acid esterase in the pathogenesis of xanthoma. A histochemical study in rabbits. Arch Dermatol Res (1977) 0.76
Aging of wound healing in an experimental model in mice. Am J Forensic Med Pathol (1988) 0.76
Lysis and growth stimulation of a murine melanoma determined by density of macrophage populations. Anticancer Res (1985) 0.76
Study of the localization of the encephalomyelitis-producing protien in the myelin sheath. Acta Neuropathol (1968) 0.75